A safer, quicker way to treat some heart arrhythmia cases could be on the horizon, creating an opportunity for these two medical device stocks.
A safer, quicker way to treat some heart arrhythmia cases could be on the horizon, creating an opportunity for medical device companies Boston Scientific and Medtronic, according to Piper Sandler analyst Matt O'Brien. Atrial fibrillation is the most common type of heart arrhythmia, according to the Centers for Disease Control and Prevention. It estimates 12.1 million people in the U.S. will have this condition in 2030.
He estimates that Boston Scientific will ring up $454 million in sales by 2025 for its Farapulse catheter. However, Medtronic appears to have the lead on a second-generation dual ablation version "by a mile," Piper Sandler said. Medtronic's Affera system has already been approved in the EU, and a trial is underway in the U.S. Unfortunately, some of its gains could cannibalize Medtronic's existing cryoablation business, he said.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Vehicle crashes near memorial maker's property in Franklin CountyA two vehicle crash in Chambersburg ended with a vehicle landing on a nearby business' property.According to Franklin Fire Company, the wreck happened on Saturd
Read more »
Eliquis maker Bristol Myers Squibb sues over Medicare plan to cut drug costsBristol Myers Squibb, maker of the blood thinner Eliquis, sued the U.S. government over a provision in the Inflation Reduction Act that would let Medicare negotiate drug prices, becoming the second major drugmaker to do so in less than two weeks.
Read more »
Tesla’s Next European Gigafactory Could Be in FranceCEO ElonMusk has been making the rounds of leaders in Spain and Italy, too, looking for the next place to plant the EV maker's flag.
Read more »
Italy rules Pirelli's Chinese top investor Sinochem cannot choose CEOThe move is meant to shield the tire maker's autonomy at a time of strained relations between China and the West.
Read more »